Pilot study: Localizing target lymph node using a magnetic marker allows reliable and representative judgement of pathological responses after neo-adjuvant ipilimumab (IPI) + nivolumab (NIVO) in macroscopic stage III melanoma

A. C.J. van Akkooi, B. Schermers, V. Franke, M. Wouters, C. L. Zuur, W. M.C. Klop, E. A. Rozeman, B. A. van de Wiel, T. J.M. Ruers, C. U. Blank

Research output: Contribution to journalArticleAcademicpeer-review

22 Downloads (Pure)
Original languageEnglish
Article number1297P
Pages (from-to)viii463
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Issue numberSupplement 8
Publication statusPublished - 1 Oct 2018
Externally publishedYes

Cite this